Browse related articlesConference on cancer and diabetes in Qatar
Qatar: Monday, November 17 - 2008 at 10:29
A two-day symposium focusing on cancer and diabetes treatments begins on Sunday at the Sharq Village and Spa, Doha. The conference, BioQatar 2008, is organised by Qatar Foundation Research Division and Qatar Science and Technology Park (QSTP) to attract biomedical ventures in Qatar. The symposium aims at providing an understanding of Qatar's strategy, infrastructure and support for commercialising cancer and diabetes technologies.
See Also
Also consider reading:
- » German orthopaedic hospital to open in 2009
- » UAE child treatment should focus on lifestyle
- » Conference focuses on organic foods
- » Free diabetes screenings in Oman
- » Diabetes centre opens in UAE
- » New hospital wing opens in Muscat
- » Johns Hopkins to manage Abu Dhabi hospital
- » Yemen to immunise 4m children
- » Call for more local heart research
- » Qatar University to conduct research on bird flu
Facebook
LinkedIn
Digg
StaffMonday, November 17 - 2008 at 10:29 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds